Neoadjuvant Therapy: What is it and When is it Used? Neoadjuvant therapy refers to treatment before surgery, and it aims to shrink the breast cancer in size to increase the chance of breast-conserving surgery and to monitor the effect of treatment on the tumour. In this podcast, Professor Prue Francis, Former Chair of the Breast Cancer Trials Scientific Advisory Committee, explains the potential benefits of neoadjuvant therapy and why it's been increasingly used in breast cancer research. Tune in for a deep dive into this important research.Like this episode? ⁠⁠Follow Breast Cancer Trials on Social Media: Instagram:⁠ ⁠⁠@breastcancertrials⁠⁠⁠ Facebook:⁠ ⁠⁠Breast Cancer Trials⁠⁠⁠ LinkedIn: ⁠⁠⁠Breast Cancer Trials⁠⁠⁠ X: ⁠⁠⁠@BCTrialsANZ⁠⁠⁠Guest: Medical Oncologist, Professor Prue Francis. Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about neoadjuvant therapy.Find out more: www.breastcancertrials.org.au

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related